Assignee
STICHTING KATHOLIEKE UNIV
NL·38 granted patents·22 pending applications·247 citations·filing 1983–2021
Top patents by PatentIndex Score
60 records- 0195US7138235B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Nov 21, 2006·43 cites·16 claims
- 0292US7960109B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Jun 14, 2011·20 cites·22 claims
- 0391US7632643B2PCA3, PCA3 genes, and methods of useSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Dec 15, 2009·20 cites·29 claims
- 0487US6897024B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2001·Granted May 24, 2005·32 cites·15 claims
- 0586US10647985B2Antisense oligonucleotides for the treatment of Leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted May 12, 2020·2 cites·14 claims
- 0685US10314508B2Brain computer interface using broadband evoked potentialsSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Jun 11, 2019·29 cites·13 claims
- 0784US10131910B2Antisense oligonucleotides for the treatment of Usher syndrome type 2STICHTING KATHOLIEKE UNIV·Filed 2015·Granted Nov 20, 2018·6 cites·7 claims
- 0883US10167470B2Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted Jan 1, 2019·3 cites·11 claims
- 0983US9096907B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Aug 4, 2015·3 cites·21 claims
- 1080US8054713B2Magneto-optical switching device and method for switching a magnetizable mediumSTICHTING KATHOLIEKE UNIV·Filed 2006·Granted Nov 8, 2011·6 cites·22 claims
- 1177US11400274B2Heart support device with directional flow assistSTICHTING KATHOLIEKE UNIV·Filed 2019·Granted Aug 2, 2022·3 cites·18 claims
- 1277US10098992B2Heart support deviceSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Oct 16, 2018·7 cites·18 claims
- 1376US8345516B2Magneto-optical switching device and method for switching a magnetizable mediumSTICHTING KATHOLIEKE UNIV·Filed 2011·Granted Jan 1, 2013·6 cites·18 claims
- 1474US10745699B2Antisense oligonucleotides for the treatment of Usher syndrome type 2STICHTING KATHOLIEKE UNIV·Filed 2018·Granted Aug 18, 2020·3 cites·24 claims
- 1572US10465230B2Chemiluminescence-based haemostasis assaySTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Nov 5, 2019·1 cites·15 claims
- 1667US12054716B2Antisense oligonucleotides for the treatment of Stargardt diseaseSTICHTING KATHOLIEKE UNIV·Filed 2021·Granted Aug 6, 2024·0 cites·11 claims
- 1767US10266809B2Polymer suitable for use in cell cultureSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Apr 23, 2019·2 cites·12 claims
- 1866US12179603B2National individual floating transport infrastructureSTICHTING KATHOLIEKE UNIV·Filed 2019·Granted Dec 31, 2024·2 cites·16 claims
- 1966US9763748B2Anatomical image projection systemSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Sep 19, 2017·5 cites·21 claims
- 2065US7691591B2Methods of identifying and isolating cells expressing DC-signSTICHTING KATHOLIEKE UNIV·Filed 2003·Granted Apr 6, 2010·1 cites·7 claims
- 2165US4916089AProcess for the epitaxial production of semiconductor stock materialSTICHTING KATHOLIEKE UNIV·Filed 1988·Granted Apr 10, 1990·32 cites·4 claims
- 2265US2009233285A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSTICHTING KATHOLIEKE UNIV·Filed 2008·Application pending·0 cites
- 2364US8920802B2Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Dec 30, 2014·1 cites·6 claims
- 2461US7541032B2Antigen uptake receptor for Candida albicans on dendritic cellsSTICHTING KATHOLIEKE UNIV·Filed 2003·Granted Jun 2, 2009·0 cites·16 claims
- 2560US2009285839A1Antigen uptake receptor for candida albicans on dendritic cellsSTICHTING KATHOLIEKE UNIV·Filed 2009·Application pending·0 cites
- 2660US2015307948A1Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 2760US2015105516A1Method for the preparation of high molecular weight oligo(alkylene glycol) functionalized polyisocyanopeptidesSTICHTING KATHOLIEKE UNIV·Filed 2014·Application pending·0 cites
- 2859US2017342414A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2017·Application pending·0 cites
- 2959US2020352977A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3058US4692542APhosphorylating agentSTICHTING KATHOLIEKE UNIV·Filed 1984·Granted Sep 8, 1987·5 cites·4 claims
- 3157US11739324B2Antisense oligonucleotides rescue aberrant splicing of ABCA4STICHTING KATHOLIEKE UNIV·Filed 2019·Granted Aug 29, 2023·0 cites·19 claims
- 3256US9259466B2Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Feb 16, 2016·0 cites·5 claims
- 3356US2022127674A1Methods for detecting circulating stromal cellsSTICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3456US2021169838A1Novel class of compounds for the treatment of cardiovascular disease.STICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3555US11236333B2Antisense oligonucleotides for the treatment of Stargardt diseaseSTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Feb 1, 2022·0 cites·12 claims
- 3648US10085779B2Intramedullary device for mid-shaft clavicle fracturesSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Oct 2, 2018·2 cites·23 claims
- 3748US2018228829A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 3847US2022049250A1Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4STICHTING KATHOLIEKE UNIV·Filed 2019·Application pending·0 cites
- 3945US2016121039A1Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4045US2009312741A1Bioresorbable composition and a medical device comprising said compositionSTICHTING KATHOLIEKE UNIV·Filed 2007·Application pending·0 cites
- 4143US4820712ASparsomycin (SC-RS) compounds having antitumor activity, a process for their preparation and pharmaceutical compositions containing sparsomycin (SC-RS) compoundsSTICHTING KATHOLIEKE UNIV·Filed 1986·Granted Apr 11, 1989·3 cites·10 claims
- 4242US2018362935A1A renal cell line with stable transporter expressionSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4341US2019038588A1Novel class of compounds for the treatment of cardiovascular diseaseSTICHTING KATHOLIEKE UNIV·Filed 2017·Application pending·0 cites
- 4441US2021087583A1Minigene for the treatment of Usher syndrome type 2a and USH2A-associated retinitis pigmentosa.STICHTING KATHOLIEKE UNIV·Filed 2019·Application pending·0 cites
- 4540US4581360ASparsomycin (Sc -Rs) derivative; pharmaceutical composition having anti-tumor activitySTICHTING KATHOLIEKE UNIV·Filed 1983·Granted Apr 8, 1986·3 cites·3 claims
- 4639US2020032347A1RNA profiling for individualized diet and treatment advice.STICHTING KATHOLIEKE UNIV·Filed 2018·Application pending·0 cites
- 4738US2018237749A1Improved method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonistSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4837US11035860B2Auto-active and intracellular mutant of METSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Jun 15, 2021·0 cites·4 claims
- 4936US11053349B2Biomimetic networks comprising polyisocyanopeptide hydrogelsSTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Jul 6, 2021·0 cites·19 claims
- 5035US11840705B2Biomimetic double network hydrogelsSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted Dec 12, 2023·0 cites·18 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →